AMG National Trust Bank held its position in shares of Cigna Corporation (NYSE:CI) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,800 shares of the health services provider’s stock at the close of the second quarter. AMG National Trust Bank’s holdings in Cigna Corporation were worth $301,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently made changes to their positions in CI. BlackRock Inc. grew its stake in shares of Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock valued at $2,488,489,000 after buying an additional 16,289,943 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Cigna Corporation by 40.8% during the 2nd quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock valued at $684,413,000 after purchasing an additional 1,184,632 shares in the last quarter. Waddell & Reed Financial Inc. lifted its holdings in Cigna Corporation by 125.8% during the 1st quarter. Waddell & Reed Financial Inc. now owns 1,749,647 shares of the health services provider’s stock worth $256,306,000 after buying an additional 974,747 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Cigna Corporation by 9.3% during the 1st quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock worth $1,577,075,000 after buying an additional 913,991 shares during the last quarter. Finally, Thrivent Financial For Lutherans lifted its holdings in Cigna Corporation by 7,868.4% during the 1st quarter. Thrivent Financial For Lutherans now owns 708,390 shares of the health services provider’s stock worth $103,772,000 after buying an additional 699,500 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.
Several analysts recently issued reports on the company. Morgan Stanley lifted their price target on Cigna Corporation from $188.00 to $195.00 and gave the company an “overweight” rating in a research report on Thursday, August 17th. BidaskClub raised Cigna Corporation from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 18th. Jefferies Group LLC reissued a “buy” rating and set a $190.00 price objective (down previously from $199.00) on shares of Cigna Corporation in a research report on Friday, August 4th. Zacks Investment Research cut Cigna Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, August 8th. Finally, Royal Bank Of Canada reiterated a “buy” rating and issued a $185.00 price objective on shares of Cigna Corporation in a research note on Wednesday, August 9th. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $181.65.
Shares of Cigna Corporation (NYSE:CI) traded up 0.23% on Friday, hitting $185.66. 286,774 shares of the stock traded hands. The stock has a 50 day moving average price of $179.12 and a 200-day moving average price of $164.84. Cigna Corporation has a 52 week low of $115.03 and a 52 week high of $188.36. The stock has a market cap of $46.75 billion, a price-to-earnings ratio of 21.42 and a beta of 0.43.
Cigna Corporation (NYSE:CI) last released its earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The company had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.98 EPS. On average, equities research analysts forecast that Cigna Corporation will post $10.02 EPS for the current year.
In other news, CEO David Cordani sold 153,168 shares of the firm’s stock in a transaction dated Monday, June 19th. The shares were sold at an average price of $170.20, for a total value of $26,069,193.60. Following the completion of the sale, the chief executive officer now directly owns 421,162 shares of the company’s stock, valued at approximately $71,681,772.40. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Chairman Isaiah Harris, Jr. sold 247 shares of the firm’s stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $185.27, for a total transaction of $45,761.69. The disclosure for this sale can be found here. Insiders have sold a total of 223,821 shares of company stock valued at $38,506,877 in the last three months. 1.30% of the stock is currently owned by corporate insiders.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with our FREE daily email newsletter.